新2最新网址www.hg108.vip)实时更新发布最新最快最有效的新2网址和新2最新网址,包括新2手机网址,新2备用网址,皇冠最新网址,新2足球网址,新2网址大全。

,Overall, 1 in 13 adults in the United States have long COVID symptoms lasting for three months or more after first contracting the disease, and which they did not have before the infection, the data showed.

Nearly 1 in 5 American adults who reported having COVID-19 in the past are still having symptoms of long COVID, according to survey data collected in the first two weeks of June, U.S. health officials said on Wednesday.

Overall, 1 in 13 adults in the United States have long COVID symptoms lasting for three months or more after first contracting the disease, and which they did not have before the infection, the data showed.

The data was collected from June 1-13 by the U.S. Census Bureau and analyzed by the U.S. Centers for Disease Control and Prevention (CDC).

Long COVID symptoms range from fatigue, rapid heartbeat, shortness of breath, cognitive difficulties, chronic pain, sensory abnormalities and muscle weakness. They can be debilitating and last for weeks or months after recovery from the initial infection.

The CDC analysis also found that younger adults were more likely to have persistent symptoms than older adults.

Women were also more likely to have long COVID than men, according to the study, with 9.4% of U.S. adult women reporting long COVID symptoms compared to 5.5% of men.

The survey found nearly 9% of Hispanic adults have long COVID, higher than non-Hispanic white and Black adults, and more than twice the percentage of non-Hispanic Asian adults.

There were also differences based on U.S states, with Kentucky and Alabama reporting the highest percentage of adults with long COVID symptoms, while Hawaii, Maryland and Virginia reported the lowest, according to the survey.- Reuters


转载说明:本文转载自Sunbet。 环球UG声明:该文看法仅代表作者自己,与本平台无关。转载请注明:新2最新网址(www.hg108.vip)_Nearly 1 in 5 adults who had COVID have lingering symptoms
发布评论

分享到:

约搏单双游戏(www.eth108.vip)_Stocks rise as calm returns after heavy selloff
你是第一个吃螃蟹的人
发表评论

◎欢迎参与讨论,请在这里发表您的看法、交流您的观点。